ReviewCurrent diabetes reports2019

Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.

Mohammad Haque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.